These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34057812)

  • 1. FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
    Maeda K; Habara M; Kawaguchi M; Matsumoto H; Hanaki S; Masaki T; Sato Y; Matsuyama H; Kunieda K; Nakagawa H; Shimada M
    Mol Oncol; 2022 Feb; 16(4):940-956. PubMed ID: 34057812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.
    Periyasamy S; Hinds T; Shemshedini L; Shou W; Sanchez ER
    Oncogene; 2010 Mar; 29(11):1691-701. PubMed ID: 20023700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.
    Yong W; Yang Z; Periyasamy S; Chen H; Yucel S; Li W; Lin LY; Wolf IM; Cohn MJ; Baskin LS; Sa Nchez ER; Shou W
    J Biol Chem; 2007 Feb; 282(7):5026-5036. PubMed ID: 17142810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.
    Joshi JB; Patel D; Morton DJ; Sharma P; Zou J; Hewa Bostanthirige D; Gorantla Y; Nagappan P; Komaragiri SK; Sivils JC; Xie H; Palaniappan R; Wang G; Cox MB; Chaudhary J
    Mol Oncol; 2017 Apr; 11(4):337-357. PubMed ID: 28252832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.
    LeMaster DM; Mustafi SM; Brecher M; Zhang J; Héroux A; Li H; Hernández G
    J Biol Chem; 2015 Jun; 290(25):15746-15757. PubMed ID: 25953903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.
    Erlejman AG; De Leo SA; Mazaira GI; Molinari AM; Camisay MF; Fontana V; Cox MB; Piwien-Pilipuk G; Galigniana MD
    J Biol Chem; 2014 Sep; 289(38):26263-26276. PubMed ID: 25104352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.
    Ni L; Yang CS; Gioeli D; Frierson H; Toft DO; Paschal BM
    Mol Cell Biol; 2010 Mar; 30(5):1243-53. PubMed ID: 20048054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.
    Cluning C; Ward BK; Rea SL; Arulpragasam A; Fuller PJ; Ratajczak T
    Mol Endocrinol; 2013 Jul; 27(7):1020-35. PubMed ID: 23686112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
    Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
    J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.
    De Leon JT; Iwai A; Feau C; Garcia Y; Balsiger HA; Storer CL; Suro RM; Garza KM; Lee S; Kim YS; Chen Y; Ning YM; Riggs DL; Fletterick RJ; Guy RK; Trepel JB; Neckers LM; Cox MB
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11878-83. PubMed ID: 21730179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease.
    Guy NC; Garcia YA; Cox MB
    Curr Mol Pharmacol; 2015; 9(2):109-25. PubMed ID: 25986565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer.
    Febbo PG; Lowenberg M; Thorner AR; Brown M; Loda M; Golub TR
    J Urol; 2005 May; 173(5):1772-7. PubMed ID: 15821585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.
    Makkonen H; Kauhanen M; Paakinaho V; Jääskeläinen T; Palvimo JJ
    Nucleic Acids Res; 2009 Jul; 37(12):4135-48. PubMed ID: 19433513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
    Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
    Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological role for the cochaperone FKBP52 in androgen receptor signaling.
    Cheung-Flynn J; Prapapanich V; Cox MB; Riggs DL; Suarez-Quian C; Smith DF
    Mol Endocrinol; 2005 Jun; 19(6):1654-66. PubMed ID: 15831525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling.
    Storer Samaniego C; Suh JH; Chattopadhyay A; Olivares K; Guy N; Sivils JC; Dey P; Yumoto F; Fletterick RJ; Strom AM; Gustafsson JÅ; Webb P; Cox MB
    PLoS One; 2015; 10(7):e0134015. PubMed ID: 26207810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity.
    Cox MB; Riggs DL; Hessling M; Schumacher F; Buchner J; Smith DF
    Mol Endocrinol; 2007 Dec; 21(12):2956-67. PubMed ID: 17717070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression.
    Bhowal A; Majumder S; Ghosh S; Basu S; Sen D; Roychowdhury S; Sengupta S; Chatterji U
    Sci Rep; 2017 Aug; 7(1):9763. PubMed ID: 28852180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
    Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
    J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.